Seasoned engineers and people with zero coding experience are embracing "vibe coding" — the act of relying on AI to write ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective upped by equities researchers at Truist Financial from $460.00 to $520.00 in a research report issued on Tuesday,Benzinga ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target hoisted by Royal Bank of Canada from $402.00 to $407.00 in a research note issued to investors on Tuesday,Benzinga reports.

Contract lifecycle management firm SpotDraft, which is backed by marquee investors such as Wipro founder-chairman Azim ...

Fintel reports that on February 12, 2025, Canaccord Genuity upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) ...

Palantir Technologies Inc. CEO Alex Karp envisions the company's legacy as strengthening Western technological supremacy while deterring adversaries, amid surging demand for artificial intelligence ...

For its fourth quarter of 2024, CRISPR booked revenue of just under $36 million. That was well under the more than $201 million the company earned in the same period of 2023. On the bottom line, ...

Edward Morrow Atkinson III, Executive Vice President and Chief Technical Operations Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), recently sold a significant portion of his holdings in the ...

Drata has acquired software security review startup SafeBase for $250 million as the former looks to scale up its offerings.

SpotDraft, an AI-driven contract lifecycle management platform, secures USD 54 million in Series B funding led by Vertex Growth Singapore and Trident Partners. The funding will accelerate global ...

The outlook offset strong fourth-quarter earnings. Vertiv reported adjusted EPS of $0.99, with revenue rising 26% ...

KUALA LUMPUR, Malaysia, Feb. 12, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”) is pleased to announce that it has secured a US$12 million contract through its subsidiary, ...